Cargando…
Risk of Hypersensitivity Reactions to Iopromide After Intra-Arterial Versus Intravenous Administration: A Nested Case-Control Analysis of 133,331 Patients
OBJECTIVE: The aim of this study was to compare the risk of hypersensitivity reactions to iopromide after intra-arterial (IA) administration and intravenous (IV) administration. MATERIALS AND METHODS: Four observational studies were pooled. Almost half of the study population (48.1%) was from Europe...
Autores principales: | Endrikat, Jan, Michel, Alexander, Kölbach, Ralf, Lengsfeld, Philipp, Vogtländer, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6903317/ https://www.ncbi.nlm.nih.gov/pubmed/31524764 http://dx.doi.org/10.1097/RLI.0000000000000611 |
Ejemplares similares
-
Risk of Hypersensitivity Reactions to Iopromide in Children and Elderly: An Analysis of 132,850 Patients From 4 Observational Studies and Pharmacovigilance Covering >288 Million Administrations
por: Endrikat, Jan, et al.
Publicado: (2022) -
Iopromide for Contrast-Enhanced Mammography: A Systemic Review and Meta-Analysis of Pertinent Literature
por: Endrikat, Jan, et al.
Publicado: (2023) -
Fixed Drug Eruption due to Iopromide (Ultravist®)
por: Cha, Sang Hee, et al.
Publicado: (2011) -
Degradation of iopromide by combined UV irradiation and peroxydisulfate
por: Chan, Ting W., et al.
Publicado: (2010) -
Efficient Degradation of Iopromide by Using Sulfite Activated with Mackinawite
por: Yu, Yingtan, et al.
Publicado: (2021)